| CAS NO: | 412950-08-4 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| CAS: | 412950-08-4 |
| 分子式: | C40H38F5N3O3S |
| 分子量: | 735.81 |
| 纯度: | >98% |
| 溶解性: | DMSO |
| 存储: | Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months;-20℃ 1 month |
| 研究领域: | Neurological Disease |
| Target: | IC50: 230 pM (Lp-PLA2) |
| 描述: | Rilapladib is a selective Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) inhibitor with an IC50 of 230 pM. |
